Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2-Reference-Cited by-同舟云学术

Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2

Published:2012-09-28 Issue:3 Volume:91 Page:357-368
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Cohen Sharon,Bruchim Ilan,Graiver Dror,Evron Zoharia,Oron-Karni Varda,Pasmanik-Chor Metsada,Eitan Ram,Bernheim Joelle,Levavi Hanoch,Fishman Ami,Flescher Eliezer

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00109-012-0946-4.pdf

Reference39 articles.

1. Partridge EE, Barnes MN (1999) Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J Clin 49:297–320

2. Bast RC Jr, Hennessy B, Mills GB (2009) The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9:415–428

3. Chaney SG, Campbell SL, Temple B, Bassett E, Wu Y, Faldu M (2004) Protein interactions with platinum-DNA adducts: from structure to function. J Inorg Biochem 98:1551–1559

4. Givant-Horwitz V, Davidson B, Lazarovici P, Schaefer E, Nesland JM, Trope CG, Reich R (2003) Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions. Gynecol Oncol 91:160–172

5. Das KC, White CW (1997) Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C. J Biol Chem 272:14914–14920

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models;2024-07-29

2. Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?;Drug Design, Development and Therapy;2024-06

3. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors;Cancer Drug Resistance;2024-02-28

4. Ovarian cancer, malignant ascites and microenvironment. Literature review;Sechenov Medical Journal;2023-08-14

5. Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses;Cancers;2023-01-21